Editas Medicine Inc. (EDIT)
NASDAQ: EDIT
· Real-Time Price · USD
1.79
0.07 (4.07%)
At close: Jun 02, 2025, 10:34 AM
4.07% (1D)
| Bid | 1.32 |
| Market Cap | 150.26M |
| Revenue (ttm) | 31.18M |
| Net Income (ttm) | -251.23M |
| EPS (ttm) | -3.04 |
| PE Ratio (ttm) | -0.59 |
| Forward PE | -1.62 |
| Analyst | Hold |
| Ask | 2.26 |
| Volume | 332,620 |
| Avg. Volume (20D) | 2,122,669 |
| Open | 1.76 |
| Previous Close | 1.72 |
| Day's Range | 1.75 - 1.83 |
| 52-Week Range | 0.91 - 6.22 |
| Beta | 2.15 |
About EDIT
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EDIT
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EDIT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts5 months ago
-23.81%
Editas Medicine shares are trading lower after Sti...
Unlock content with
Pro Subscription
5 months ago
-5.03%
Editas Medicine shares are trading higher after the company announced plans to transition to an in vivo focus and initiated a reduction in headcount, aiming to eliminate approximately 65% of its workforce over the next six months.
